Breaking Finance News

HCP, Inc. (NYSE:HCP) target price increased to $32.00, issued a research note today by Mitsubishi UFJ Financial Group

In a report released on 4/21/2017 Mitsubishi UFJ Financial Group increased the stock price target of HCP, Inc. (NYSE:HCP) to $32.00 stating a potential downside of -0.01%.

Boasting a price of $32.48, HCP, Inc. (NYSE:HCP) traded -0.15% lower on the day. With the last close up 5.72% from the two hundred day average, compared with the S&P 500 Index which has increased 0.03% over the date range. HCP, Inc. has recorded a 50-day average of $31.07 and a two hundred day average of $30.71. Volume of trade was down over the average, with 1,430,005 shares of HCP changing hands under the typical 4,247,420

Performance Chart

HCP, Inc. (NYSE:HCP)

With a total market value of $0, HCP, Inc. has price-earnings ratio of 24.25 with a one year low of $27.61 and a one year high of $40.43 .

A total of 12 analysts have released a research note on HCP. zero analysts rating the company a strong buy, one analyst rating the company a buy, ten analysts rating the company a hold, five analysts rating the company a underperform, and finally one analyst rating the company a sell with a one year target of $31.42.

More About HCP, Inc. (NYSE:HCP)

HCP, Inc. is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company's segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities. Its Life science properties contain laboratory and office space for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies and other organizations. Its Medical office buildings contain physicians' offices and examination rooms, and may include pharmacies, hospital ancillary service space and outpatient services. As of December 31, 2016, it had interests in and managed 15 hospitals, 61 care homes in the United Kingdom and five post-acute/skilled nursing facilities.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.